IL17A and psoriasis: As shown in Figures 6A, B and Supplementary Figures S5A, B, these psoriasis-associated inflammatory parameters in the back and ear skin significantly decreased after the administration of 60 μg of ndSTAT1-TMD or anti-IL-17A antibody.